Keywords: biomira, 1st-qtr, losses, decline, canada, reported, consolidated
Biomira 1st-qtr losses decline
Article | 13 May 2002
Biomira of Canada has reported a consolidated net loss from operationsfor first-quarter 2002 of C$7.6 million ($4.8 million), or C$0.17 per share, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
